Molecular Medicine (ex Biomedical Sciences and Biotechnology)

The Ph.D. Programme will be activated for the 2023/2024 a.y. (39th cycle) after ministerial accreditation.

The aim of the PhD programme is to train highly qualified personnel capable of independently tackling and conducting advanced research topics in the field of biomedical sciences and their biotechnological applications.
The fundamental training aspect for a student in this PhD programme is the daily relationship with his or her research project and the related experimental activity accompanied by a constant and productive dialogue between the students and lecturers and researchers.

The diverse cultural background of the lecturers in the doctoral college has a positive impact on the students who can ineract in a multidisciplinary environment with complementary points of view.
Students have the opportunity to follow a customised training path that includes transversal and disciplinary activities and are also encouraged to spend time abroad to improve their research and promote international scientific collaborations. Students have independent access to doctoral course funds to cover the costs of lectures, courses and consumables

    • BIO/09 - Fisiologia;
    • BIO/10 - Biochimica;
    • BIO/11 - Biologia molecolare;
    • BIO/13 - Biologia applicata;
    • BIO/14 - Farmacologia;
    • BIO/16 - Anatomia umana;
    • FIS/07 - Fisica applicata (a beni culturali, ambientali, biologia e medicina);
    • MED/04 - Patologia generale;
    • MED/16 - Reumatologia
    • MED/18 - Chirurgia generale;
    • MED/42 - Igiene generale e applicata;
    • M-EDF/01 - Metodi e didattiche delle attività motorie;
    • VET/01 - Anatomia degli animali domestici.

In the academic world, the PhD qualification certainly represents an added value in comparative assessments for the recruitment of future professors and in some cases is compulsory. In addition to the academic world, the PhD course in Molecular Medicine prepares researchers who, having acquired project skills and a high scientific qualification during their training, are able to transfer a true culture of innovation and research to hospitals and health and industrial research facilities.

An effort that the doctoral course has made and will continue to make is to grow and mature an entrepreneurial awareness as well. This is a crucial aspect since the landscape of biotech companies in Italy is not particularly rich and spaces for new activities do exist. 

Therefore, while employment in the academy of our PhDs reflects international standards (less than 20% of PhDs in the USA), what is lacking in Italy is a prospect for the remaining 80%. Forceful play in the country's current conditions, it is necessary for new doctorates to create new prospects. For this reason, training courses are organised in the field of IP (intellectual property), patenting and the creation of start-ups.

University of Udine, Department of Medical Area (DAME) –via Colugna 50, 33100 Udine, ITALY (tel. +39 0432 494301).

C.R.O. - Centro di Riferimento Oncologico (National Cancer Institute Aviano) – via Franco Gallini 2, 33081 Aviano (PN) ITALY.